Dr. Gopi K. Manthripragada, MD

Dr. Manthripragada practices at San Francisco Medical Center in San Francisco, California, part of Kaiser Permanente.

Dr. Manthripragada's NPI, 1447441209, was assigned on August 7, 2007. Dr. Manthripragada graduated from Feinberg School of Medicine in 2004. Dr. Manthripragada's Massachusetts license number on file is 251304.

Dr. Manthripragada's primary practice is San Francisco Medical Center, at 2425 Geary Blvd, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 833-2646.

Dr. Manthripragada's primary practice is San Francisco Medical Center in San Francisco, California, part of Kaiser Permanente. Dr. Manthripragada is also affiliated with Massachusetts General Hospital. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Manthripragada to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manthripragada practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Manthripragada's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Manthripragada is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Manthripragada's licenses on file in 6 states: Massachusetts, California, Tennessee, Pennsylvania, Virginia and District of Columbia.

Dmand AI lists cardiac catheterization among the conditions Dr. Manthripragada treats.

CMS data shows 12 Medicare services from Dr. Manthripragada across 1 procedure code in 2024, for 17 Medicare patients. Medicare paid $86 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 17 Medicare patients who saw Dr. Manthripragada in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manthripragada's median patient age at 64, with 46% women.

In 2024, Dr. Manthripragada wrote 221 Medicare Part D claims for 55 patients. 77% of them were for generic drugs. CMS names the drug for 147 of them, across 7 drugs with 11 or more claims each, at $14,968 in total drug cost. In 2023, CMS named 96 claims across 5 drugs.

Dr. Manthripragada accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Manthripragada in 2016. Dr. Manthripragada's most frequent co-authors are Jason A. Hove, MD, Michael Sung Lee, MD and Raymond W. Liu, MD.

CMS Open Payments shows 61 general payments to Dr. Manthripragada from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Abbott Laboratories paid the most, $1,371.

Dr. Manthripragada graduated from Feinberg School of Medicine in 2004. Dr. Manthripragada is a member of ACC.

Dr. Manthripragada is in network with 3 carriers, including Excellus BlueCross BlueShield, Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.